Literature DB >> 14617754

Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein.

Manuel Yepes1, Maria Sandkvist, Elizabeth G Moore, Thomas H Bugge, Dudley K Strickland, Daniel A Lawrence.   

Abstract

The regulation of cerebrovascular permeability is critical for normal brain homeostasis, and the "breakdown" of the blood-brain barrier (BBB) is associated with the development of vasogenic edema and intracranial hypertension in a number of neurological disorders. In this study we demonstrate that an increase in endogenous tissue-type plasminogen activator (tPA) activity in the perivascular tissue following cerebral ischemia induces opening of the BBB via a mechanism that is independent of both plasminogen (Plg) and MMP-9. We also show that injection of tPA into the cerebrospinal fluid in the absence of ischemia results in a rapid dose-dependent increase in vascular permeability. This activity is not seen with urokinase-type Plg activator (uPA) but is induced in Plg-/- mice, confirming that the effect is Plg-independent. However, the activity is blocked by antibodies to the LDL receptor-related protein (LRP) and by the LRP antagonist, receptor-associated protein (RAP), suggesting a receptor-mediated process. Together these studies demonstrate that tPA is both necessary and sufficient to directly increase vascular permeability in the early stages of BBB opening, and suggest that this occurs through a receptor-mediated cell signaling event and not through generalized degradation of the vascular basement membrane.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14617754      PMCID: PMC259131          DOI: 10.1172/JCI19212

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  46 in total

1.  Proteolytic processing of low density lipoprotein receptor-related protein mediates regulated release of its intracellular domain.

Authors:  Petra May; Y Krishna Reddy; Joachim Herz
Journal:  J Biol Chem       Date:  2002-03-20       Impact factor: 5.157

2.  The low density lipoprotein receptor-related protein modulates levels of matrix metalloproteinase 9 (MMP-9) by mediating its cellular catabolism.

Authors:  E Hahn-Dantona; J F Ruiz; P Bornstein; D K Strickland
Journal:  J Biol Chem       Date:  2001-02-02       Impact factor: 5.157

3.  Role of tissue plasminogen activator receptor LRP in hippocampal long-term potentiation.

Authors:  M Zhuo; D M Holtzman; Y Li; H Osaka; J DeMaro; M Jacquin; G Bu
Journal:  J Neurosci       Date:  2000-01-15       Impact factor: 6.167

4.  The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling.

Authors:  O Nicole; F Docagne; C Ali; I Margaill; P Carmeliet; E T MacKenzie; D Vivien; A Buisson
Journal:  Nat Med       Date:  2001-01       Impact factor: 53.440

5.  Tissue plasminogen activator (tPA) deficiency exacerbates cerebrovascular fibrin deposition and brain injury in a murine stroke model: studies in tPA-deficient mice and wild-type mice on a matched genetic background.

Authors:  P Tabrizi; L Wang; N Seeds; J G McComb; S Yamada; J H Griffin; P Carmeliet; M H Weiss; B V Zlokovic
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-11       Impact factor: 8.311

6.  Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia.

Authors:  M Asahi; X Wang; T Mori; T Sumii; J C Jung; M A Moskowitz; M E Fini; E H Lo
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

7.  LDL receptor-related protein mediates uptake of aggregated LDL in human vascular smooth muscle cells.

Authors:  V Llorente-Cortés; J Martínez-González; L Badimon
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-06       Impact factor: 8.311

8.  Neuroserpin reduces cerebral infarct volume and protects neurons from ischemia-induced apoptosis.

Authors:  M Yepes; M Sandkvist; M K Wong; T A Coleman; E Smith; S L Cohan; D A Lawrence
Journal:  Blood       Date:  2000-07-15       Impact factor: 22.113

9.  Neuroserpin, a neuroprotective factor in focal ischemic stroke.

Authors:  P Cinelli; R Madani; N Tsuzuki; P Vallet; M Arras; C N Zhao; T Osterwalder; T Rülicke; P Sonderegger
Journal:  Mol Cell Neurosci       Date:  2001-11       Impact factor: 4.314

10.  Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94.

Authors:  M Asahi; K Asahi; J C Jung; G J del Zoppo; M E Fini; E H Lo
Journal:  J Cereb Blood Flow Metab       Date:  2000-12       Impact factor: 6.200

View more
  227 in total

1.  Signaling through LRP1: Protection from atherosclerosis and beyond.

Authors:  Philippe Boucher; Joachim Herz
Journal:  Biochem Pharmacol       Date:  2010-10-30       Impact factor: 5.858

2.  LRP: a bright beacon at the blood-brain barrier.

Authors:  Joachim Herz
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

Review 3.  Blood-brain barrier breakdown in acute and chronic cerebrovascular disease.

Authors:  Yi Yang; Gary A Rosenberg
Journal:  Stroke       Date:  2011-09-22       Impact factor: 7.914

Review 4.  The contribution of L-arginine to the neurotoxicity of recombinant tissue plasminogen activator following cerebral ischemia: a review of rtPA neurotoxicity.

Authors:  George W J Harston; Brad A Sutherland; James Kennedy; Alastair M Buchan
Journal:  J Cereb Blood Flow Metab       Date:  2010-08-25       Impact factor: 6.200

5.  Novel plasminogen activator inhibitor-1-derived peptide protects against impairment of cerebrovasodilation after photothrombosis through inhibition of JNK MAPK.

Authors:  William M Armstead; John Riley; J Willis Kiessling; Douglas B Cines; Abd Al-Roof Higazi
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-06-10       Impact factor: 3.619

Review 6.  Lipoprotein receptors--an evolutionarily ancient multifunctional receptor family.

Authors:  Marco Dieckmann; Martin Frederik Dietrich; Joachim Herz
Journal:  Biol Chem       Date:  2010-11       Impact factor: 3.915

7.  Endothelial NOS-deficient mice reveal dual roles for nitric oxide during experimental autoimmune encephalomyelitis.

Authors:  Muzhou Wu; Stella E Tsirka
Journal:  Glia       Date:  2009-08-15       Impact factor: 7.452

Review 8.  Hemorrhagic transformation after ischemic stroke in animals and humans.

Authors:  Glen C Jickling; DaZhi Liu; Boryana Stamova; Bradley P Ander; Xinhua Zhan; Aigang Lu; Frank R Sharp
Journal:  J Cereb Blood Flow Metab       Date:  2013-11-27       Impact factor: 6.200

9.  Tissue-type plasminogen activator and the low-density lipoprotein receptor-related protein mediate cerebral ischemia-induced nuclear factor-kappaB pathway activation.

Authors:  Xiaohui Zhang; Rohini Polavarapu; Hua She; Zixu Mao; Manuel Yepes
Journal:  Am J Pathol       Date:  2007-08-23       Impact factor: 4.307

10.  Platelet-Specific Chemokines Contribute to the Pathogenesis of Acute Lung Injury.

Authors:  Khalil Bdeir; Kandace Gollomp; Marta Stasiak; Junjie Mei; Izabela Papiewska-Pajak; Guohua Zhao; G Scott Worthen; Douglas B Cines; Mortimer Poncz; M Anna Kowalska
Journal:  Am J Respir Cell Mol Biol       Date:  2017-02       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.